Acquired Factor XIII Deficiency Disease

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Acquired Factor XIII Deficiency Disease trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

CompletedNot Applicable

NCT03634215

Estimation of Coagulation Factor XIII Activity Based on the Initial Plasma Fibrinogen Level in Trauma

Coagulation factor XIII (FXIII), a plasma transglutaminase, is known as the final enzyme of the coagulation cascade, responsible for a cross-linking of fibrin t…

Czechia357 participantsStarted 2018-09-01

Treatment: fibrinogen plasma concentration, coagulation factor XIII activity

CompletedNot Applicable

NCT04416594

Impact of Acquired FXIII Deficiency on Morbidity and Mortality

Observational prospective study aiming to assess acquired FXIII deficiency implications in morbidity and mortality

Spain50 participantsStarted 2019-09-10

Treatment: Data collection